Claus Henrik Nielsen

Claus Henrik Nielsen

Professor

ORCID: 0000-0001-7543-9016

Publication year:
All
31 - 40 out of 158Page size: 10
  1. 2007
  2. Published

    Gene expression profiling in autoimmune diseases: chronic inflammation or disease specific patterns?

    Bovin, L. F., Brynskov, J., Hegedüs, L., Jess, T., Nielsen, Claus Henrik & Bendtzen, K., 1 May 2007, In: Autoimmunity. 40, 3, p. 191-201 11 p.

    Research output: Contribution to journal › Journal article › Research

  3. Published

    Methotrexate induces poly(ADP-ribose) polymerase-dependent, caspase 3-independent apoptosis in subsets of proliferating CD4+ T cells

    Nielsen, Claus Henrik, Albertsen, L., Bendtzen, K. & Baslund, B., 1 May 2007, In: Clinical and Experimental Immunology. 148, 2, p. 288-95 8 p.

    Research output: Contribution to journal › Journal article › Research

  4. Published

    B-cell depletion with rituximab in the treatment of autoimmune diseases. Graves' ophthalmopathy the latest addition to an expanding family

    Nielsen, Claus Henrik, Fassi, Daniel El , Hasselbalch, H. K., Bendtzen, K. & Hegedüs, L., 1 Jul 2007, In: Expert Opinion on Biological Therapy. 7, 7, p. 1061-78 18 p.

    Research output: Contribution to journal › Journal article › Research

  5. Published

    Evidence of intrathyroidal B-lymphocyte depletion after rituximab therapy in a patient with Graves' disease

    Fassi, Daniel El , Clemmensen, O., Nielsen, Claus Henrik, Silkiss, R. Z. & Hegedüs, L., 1 Oct 2007, In: Journal of Clinical Endocrinology and Metabolism. 92, 10, p. 3762-3 2 p.

    Research output: Contribution to journal › Journal article › Research

  6. 2008
  7. Published

    Application of new therapies in Graves' disease and thyroid-associated ophthalmopathy: animal models and translation to human clinical trialsTumor necrosis factor-alpha binding capacity and anti-infliximab antibodies measured by fluid-phase radioimmunoassays as predictors of clinical efficacy of infliximab in Crohn's disease

    Banga, J. P., Gilbert, J. A., El, F. D., Hegedus, L. & Nielsen, Claus Henrik, 2008, In: Thyroid. 18, 9, p. 973-981 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    B-lymfocytdepletring og andre biologiske behandlingsmuligheder ved Graves' oftalmopatiTumor necrosis factor-alpha binding capacity and anti-infliximab antibodies measured by fluid-phase radioimmunoassays as predictors of clinical efficacy of infliximab in Crohn's disease

    El, F. D., Hegedus, L. & Nielsen, Claus Henrik, 2008, In: Ugeskrift for læger. 170, 24, p. 2128-2130 2 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Reduced folate carrier polymorphism determines methotrexate uptake by B cells and CD4+ T cellsTumor necrosis factor-alpha binding capacity and anti-infliximab antibodies measured by fluid-phase radioimmunoassays as predictors of clinical efficacy of infliximab in Crohn's disease

    Baslund, B., Gregers, J. & Nielsen, Claus Henrik, 2008, In: Rheumatology.(Oxford). 47, 4, p. 451-453 2 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Treatment of Graves' disease with rituximab specifically reduces the production of thyroid stimulating autoantibodies

    Fassi, Daniel El , Banga, J. P., Gilbert, J. A., Padoa, C., Hegedüs, L. & Nielsen, Claus Henrik, 2008, In: Clinical Immunology. 130, 3, p. 252-8 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' diseaseTumor necrosis factor-alpha binding capacity and anti-infliximab antibodies measured by fluid-phase radioimmunoassays as predictors of clinical efficacy of infliximab in Crohn's disease

    El, F. D., Kjeldsen, J., Clemmensen, O., Hegedus, L. & Nielsen, Claus Henrik, 2008, In: Gut. 57, 5, p. 714-715 1 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    Reduced folate carrier polymorphism determines methotrexate uptake by B cells and CD4+ T cells

    Baslund, B., Gregers, J. & Nielsen, Claus Henrik, 1 Apr 2008, In: Rheumatology. 47, 4, p. 451-3 3 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...16 Next

ID: 927479